Alpha 2.0
Login Register
» Authors » A Hattersley

A Hattersley

Explore the profile of A Hattersley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 163
Followers 0
Related Specialties
Endocrinology
General Medicine
Neurology
Top 10 Co-Authors
S Ellard
S R Bloom
R Turner
K MacLeod
K Meeran
R L Holder
C Tomson
R E J Besser
J Cook
J Burrin
Published In
Lancet
Diabet Med
Br J Anaesth
J Clin Endocrinol Metab
Ann Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes
Hope S, Jones A, Goodchild E, Shepherd M, Besser R, Shields B, et al.
Diabet Med . 2013 May; 30(11):1342-8. PMID: 23659458
Aims: To determine the prevalence and clinical characteristics of absolute insulin deficiency in long-standing Type 2 diabetes, using a strategy based on home urinary C-peptide creatinine ratio measurement. Methods: We...
2.
A novel GATA6 mutation leading to congenital heart defects and permanent neonatal diabetes: a case report
Catli G, Abaci A, Flanagan S, De Franco E, Ellard S, Hattersley A, et al.
Diabetes Metab . 2013 May; 39(4):370-4. PMID: 23639568
Permanent neonatal diabetes mellitus is a rare condition mostly due to heterozygous mutations in the KCNJ11, ABCC8 and INS genes. Neonatal diabetes due to pancreatic agenesis is extremely rare. Mutations...
3.
A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data
de Lusignan S, Khunti K, Belsey J, Hattersley A, van Vlymen J, Gallagher H, et al.
Diabet Med . 2010 Jun; 27(2):203-9. PMID: 20546265
Aims: Incorrect classification, diagnosis and coding of the type of diabetes may have implications for patient management and limit our ability to measure quality. The aim of the study was...
4.
Maturity onset diabetes of the young (MODY) and early onset Type II diabetes are not caused by loss of imprinting at the transient neonatal diabetes (TNDM) locus
Shield J, Owen K, Robinson D, Mackay D, Ellard S, Hattersley A, et al.
Diabetologia . 2001 Aug; 44(7):924. PMID: 11508282
No abstract available.
5.
Growth-hormone treatment and risk of diabetes
Spyer G, Ellard S, Hattersley A
Lancet . 2000 Jun; 355(9218):1913-4. PMID: 10866472
No abstract available.
6.
The HOPE study and diabetes. Heart Outcomes Prevention Evaluation
Fegan G, Ward D, Clarke L, MacLeod K, Hattersley A
Lancet . 2000 May; 355(9210):1182-3; author reply 1183-4. PMID: 10791400
No abstract available.
7.
Can molecular genetics help in the clinic?
Hattersley A
Diabet Med . 1999 Oct; 16(9):788-91. PMID: 10510959
No abstract available.
8.
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33
Heward J, Allahabadia A, Armitage M, Hattersley A, Dodson P, MacLeod K, et al.
J Clin Endocrinol Metab . 1999 Jul; 84(7):2398-401. PMID: 10404810
Case-control studies suggest that the CTLA-4 gene may be a susceptibility locus for Graves' disease. The previously reported A/G polymorphism at position 49 in exon 1 of the CTLA-4 gene...
9.
Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia
Matyka K, Beards F, Appleton M, Ellard S, Hattersley A, Dunger D
Arch Dis Child . 1998 Aug; 78(6):552-4. PMID: 9713013
Mild hyperglycaemia is a common finding during minor illness in children. The differential diagnosis includes maturity onset diabetes of the young (MODY), which can be a difficult diagnosis to make...
10.
Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels
Meeran K, Hattersley A, Burrin J, Shiner R, IBBERTSON K
Am J Respir Crit Care Med . 1995 Feb; 151(2 Pt 1):333-6. PMID: 7842187
Osteoporosis is a well-known, serious complication of long-term high-dose corticosteroid therapy. This study was performed to determine the effects of commonly used doses of oral and inhaled steroids on biochemical...